Phase 1 to Phase 4: A Friendly Road Map for Volunteers

Clinical studies often come with labels such as “Phase 1” or “Phase 3.” These labels are not ratings, and a later phase is not automatically the right choice for everyone. Each phase simply answers different questions about a medicine, vaccine, or other health approach.

Understanding the phases can help you compare opportunities, prepare for screening, and decide what feels comfortable for you.

Before the numbered phases

Some research happens before people are invited to participate. Researchers may test an approach in a laboratory and gather information required before human studies can begin.

There are also studies that do not fit neatly into numbered phases. For example, researchers may observe health habits, collect survey responses, or evaluate medical devices. If a listing does not mention a phase, that does not necessarily mean anything is missing. Ask the study team what type of research it is and what participation involves.

Phase 1: Learning the basics

Phase 1 is usually the first time a new treatment is studied in people. These studies generally include a relatively small number of volunteers. Researchers focus on questions such as:

• How does the body respond?
• What amount can be given safely?
• What side effects may occur?
• How often should it be given?

Some Phase 1 studies enroll healthy volunteers, while others need people with a specific health condition. Visits may be longer or more frequent because the research team is collecting early information and watching participants closely.

Early-phase research may involve more unknowns than later phases. Before enrolling, ask what is already known, what remains uncertain, and what safety checks are included.

Phase 2: Looking for signs it may help

After an approach has passed initial testing, Phase 2 usually studies it in a larger group of people who have the condition being researched.

Researchers continue to monitor side effects while looking for signs that the approach works as intended. They may also compare different amounts or schedules.

Participation could include:

• Regular clinic visits
• Health checks or laboratory tests
• Questionnaires or symptom tracking
• Taking the study treatment on a schedule
• Calls or app-based check-ins between visits

The exact routine varies widely. Request a visit calendar so you can see how the study might fit around work, school, caregiving, or transportation needs.

Phase 3: Comparing on a larger scale

Phase 3 studies often include hundreds or thousands of participants, sometimes across several locations. Their goal is to gather stronger evidence about benefits and risks.

A new approach may be compared with the usual treatment, another treatment, or an inactive comparison called a placebo. Participants are often assigned to groups by chance. In some studies, neither the participant nor the study staff knows who receives which option until the study ends.

Ask the team to explain:

• What groups are included
• How assignment works
• Whether a placebo is possible
• How long participation lasts
• What happens if your health changes
• Whether your usual care may be affected

The consent form should describe these details, but you can ask the team to explain anything that is unclear before you decide.

Phase 4: Learning more after approval

Phase 4 research happens after a treatment has been approved for public use. Researchers may study how it works over a longer period, how it affects different groups, or whether less-common side effects appear when more people use it.

These studies can still require appointments, tests, diaries, or follow-up calls. “Already approved” does not mean participation is risk-free or that the study requires no extra effort. Review the schedule and possible risks just as carefully as you would for any other opportunity.

What a phase does—and does not—tell you

The phase gives you a broad idea of the study’s main purpose. It does not tell you everything about your personal experience.

Studies within the same phase can differ in:

• Number and length of visits
• Overnight stays
• Blood draws or other procedures
• Study duration
• Eligibility requirements
• Possible risks and benefits
• Reimbursement or compensation

Compensation varies by study and may reflect time, travel, procedures, or other participation requirements. Ask what is offered, when it is provided, whether taxes may apply, and which expenses are reimbursed. Payment should not replace a careful review of the study’s demands and risks.

Questions to help you compare studies

No matter which phase you are considering, useful questions include:

• What is the main goal of this study?
• Why might I qualify?
• What is already known about the study approach?
• What side effects or inconveniences are possible?
• How many visits, calls, or overnight stays are required?
• Can I continue my current medicines?
• Who should I contact if I feel unwell?
• What happens if I decide to leave early?
• What costs might I have?
• How and when is compensation provided?

Joining research is voluntary. You can take time to read the consent form, discuss the opportunity with people you trust, and ask follow-up questions. You may also choose not to join or decide to leave later, although it is helpful to ask the team how to do so safely.

The simple takeaway

Think of the phases as steps in a learning process: Phase 1 explores basic safety and use, Phase 2 looks for early signs of benefit, Phase 3 tests the approach in larger groups, and Phase 4 continues learning after approval.

The best fit depends on your health, schedule, comfort with uncertainty, and the specific study—not simply its phase number. Read each listing carefully and speak openly with the research team before making your choice.

*This article provides general information and is not medical advice. Talk with a qualified healthcare professional about decisions related to your health or study participation.*